Evidence map›Paper›PMID 30143703›Full record

ArticleScientific reports2018

Alteration of β-Adrenoceptor Signaling in Left Ventricle of Acute Phase Takotsubo Syndrome: a Human Study.

Tomoya Nakano, Kenji Onoue, Yasuki Nakada, Hitoshi Nakagawa, Takuya Kumazawa, Tomoya Ueda, Taku Nishida, Tsunenari Soeda, Satoshi Okayama, Makoto Watanabe and 8 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Perioperative management of Takotsubo cardiomyopathy: an overview.Journal of anesthesia, analgesia and critical care · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Molecular Mechanisms of Takotsubo Syndrome.International journal of molecular sciences · 2022
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Tomoya NakanoFirst Department of Internal Medicine, Nara Medical University, Kashihara Nara, Japan.
Kenji OnoueFirst Department of Internal Medicine, Nara Medical University, Kashihara Nara, Japan. konoue@naramed-u.ac.jp.
Yasuki NakadaFirst Department of Internal Medicine, Nara Medical University, Kashihara Nara, Japan.
Hitoshi NakagawaFirst Department of Internal Medicine, Nara Medical University, Kashihara Nara, Japan.
Takuya KumazawaFirst Department of Internal Medicine, Nara Medical University, Kashihara Nara, Japan.
Tomoya UedaFirst Department of Internal Medicine, Nara Medical University, Kashihara Nara, Japan.
Taku NishidaFirst Department of Internal Medicine, Nara Medical University, Kashihara Nara, Japan.
Tsunenari SoedaFirst Department of Internal Medicine, Nara Medical University, Kashihara Nara, Japan.
Satoshi OkayamaFirst Department of Internal Medicine, Nara Medical University, Kashihara Nara, Japan.
Makoto WatanabeFirst Department of Internal Medicine, Nara Medical University, Kashihara Nara, Japan.
Hiroyuki KawataFirst Department of Internal Medicine, Nara Medical University, Kashihara Nara, Japan.
Rika KawakamiFirst Department of Internal Medicine, Nara Medical University, Kashihara Nara, Japan.
Manabu HoriiFirst Department of Internal Medicine, Nara Medical University, Kashihara Nara, Japan.
Hiroyuki OkuraFirst Department of Internal Medicine, Nara Medical University, Kashihara Nara, Japan.
Shiro UemuraFirst Department of Internal Medicine, Nara Medical University, Kashihara Nara, Japan.
Kinta HatakeyamaDepartment of Diagnostic Pathology, Nara Medical University, Kashihara Nara, Japan.
Yasuhiro SakaguchiFirst Department of Internal Medicine, Nara Medical University, Kashihara Nara, Japan.
Yoshihiko SaitoFirst Department of Internal Medicine, Nara Medical University, Kashihara Nara, Japan.
Nara Medical University · JPKawasaki Medical School · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence indicates alteration of the β-adrenoceptor (AR), such as desensitization and subtype switching of its coupling G protein, plays a role in the protection against catecholamine toxicity in heart failure. However, in human takotsubo syndrome (TTS), which is associated with a surge of circulating catecholamine in the acute phase, there is no histologic evidence of β-AR alteration. The purpose of this study was to investigate the involvement of alteration of β-AR signaling in the mechanism of TTS development. Left ventricular (LV) biopsied samples from 26 patients with TTS, 19 with normal LV function, and 26 with dilated cardiomyopathy (DCM) were studied. G protein-coupled receptor kinase 2 (GRK2) and β-arrestin2, which initiate the alteration of β-AR signaling, were more abundantly expressed in the myocardium in acute-phase TTS than in those of DCM and normal control as indicated by immunohistochemistry. The percentage of cardiomyocytes that showed positive membrane staining for GRK2 and β-arrestin2 was also significantly higher in acute-phase TTS. Sequential biopsies in the recovery-phase for two patients with TTS revealed that membrane expression of GRK2 and β-arrestin2 faded over time. This study provided the first histologic evidence of the involvement of alteration of β-ARs in the development of TTS.

Indexed as

Signal Transduction8-Hydroxy-2'-DeoxyguanosineAgedbeta-ArrestinsDeoxyguanosineFemaleG-Protein-Coupled Receptor Kinase 2Heart VentriclesHumansMaleMiddle AgedPhosphorylationReceptors, Adrenergic, betaTakotsubo Cardiomyopathy8-Hydroxy-2'-Deoxyguanosinebeta-ArrestinsDeoxyguanosineG-Protein-Coupled Receptor Kinase 2Receptors, Adrenergic, beta

Identifiers

PMID30143703
PMCPMC6109068
OpenAlexW2888499992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.